S. 5297 — American Pharmaceutical Security Act

This section directs the Administrator of the Centers for Medicare & Medicaid Services to submit a report to Congress within 1 year of enactment on using coverage and reimbursement authorities to protect U.S. and allied markets for active pharmaceutical ingredients and key starting materials and reduce dependence on foreign adversaries. The report may include recommendations for price floor commitments supporting domestic manufacturing and for prioritizing domestic sources when available, and must identify gaps in data on origin and ownership.